Recombinant Adeno-Associated Virus Gene Therapy for Cystic Fibrosis and α1-Antitrypsin Deficiency

This publication has 24 references indexed in Scilit:

• A Phase II, Double-Blind, Randomized, Placebo-Controlled Clinical Trial of tgAAVCF Using Maxillary Sinus Delivery in Patients with Cystic Fibrosis with Antrostomies
  Human Gene Therapy, 2002
• Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
  Proceedings of the National Academy of Sciences, 1998
• A Phase I/II Study of tgAAV-CF for the Treatment of Chronic Sinusitis in Patients with Cystic Fibrosis. Stanford University, Stanford, California
  Human Gene Therapy, 1998
• [53] Adeno-associated virus vectors for gene therapy of cystic fibrosis
  Published by Elsevier ,1998
• A Phase I Study of an Adeno-Associated Virus-CFTR Gene Vector in Adult CF Patients with Mild Lung Disease. Johns Hopkins Children's Center, Baltimore, Maryland
  Human Gene Therapy, 1996
• The cryptic life style of adenoassociated virus
  BioEssays, 1995
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.
  Proceedings of the National Academy of Sciences, 1993
• Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells
  American Journal of Respiratory Cell and Molecular Biology, 1992
• Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR
  Nature, 1992
• EPIDEMIOLOGY OF ADENOVIRUS-ASSOCIATED VIRUS INFECTION IN A NURSERY POPULATION1
  American Journal of Epidemiology, 1968